Hormonal influences in multiple sclerosis: New therapeutic benefits for steroids

Maturitas

Volumn 68, Issue 1, 2011, Pages 47-51

  El Etr, Martine ^a   Ghoumari, Abdel ^a   Sitruk Ware, Régine ^b   Schumacher, Michael ^a  

^a Universite Paris Sud   (France)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Estradiol; Multiple sclerosis; Myelin; Neuroprotection; Progesterone; Progestins

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ESTRADIOL; GELATINASE B; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; PLACEBO; PROGESTERONE; TESTOSTERONE;

ABSENCE OF SIDE EFFECTS; ALLERGIC ENCEPHALOMYELITIS; CLINICAL TRIAL; DEMYELINATION; ENDOMETRIUM HYPERPLASIA; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; LOW DRUG DOSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; REMYELINIZATION; REVIEW; SEX DIFFERENCE;

ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEURONS; PROGESTINS;

EID: 78650589847     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.09.014     Document Type: Review

References (70)

1. A. Fromont, C. Binquet, and E.A. Sauleau Geographic variations of multiple sclerosis in France Brain 133 2010 1889 1899
2. C.W. Noonan, S.J. Kathman, and M.C. White Prevalence estimates for MS in the United States and evidence of an increasing trend for women Neurology 58 2002 136 138
3. J. Bentzen, E.M. Flachs, E. Stenager, H. Bronnum-Hansen, and N. Koch-Henriksen Prevalence of multiple sclerosis in Denmark 1950-2005 Mult Scler 16 2010 520 525
4. H. Lassmann, W. Bruck, and C.F. Lucchinetti The immunopathology of multiple sclerosis: an overview Brain Pathol 17 2007 210 218
5. P. Patrikios, C. Stadelmann, and A. Kutzelnigg Remyelination is extensive in a subset of multiple sclerosis patients Brain 129 2006 3165 3172
6. R.J. Franklin, and C. Ffrench-Constant Remyelination in the CNS: from biology to therapy Nat Rev Neurosci 9 2008 839 855
7. O. Aktas, B. Kieseier, and H.P. Hartung Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis Trends Neurosci 33 2010 140 152
8. K.M. Myhr, and S.I. Mellgren Corticosteroids in the treatment of multiple sclerosis Acta Neurol Scand Suppl 189 2009 73 80
9. M. Schumacher, R. Sitruk-Ware, and A.F. De Nicola Progesterone and progestins: neuroprotection and myelin repair Curr Opin Pharmacol 8 2008 740 746
10. C. Confavreux, and S. Vukusic Age at disability milestones in multiple sclerosis Brain 129 2006 595 605
11. A. Zorgdrager, and J. De Keyser The premenstrual period and exacerbations in multiple sclerosis Eur Neurol 48 2002 204 206
12. P. Holmqvist, M. Wallberg, M. Hammar, A.M. Landtblom, and J. Brynhildsen Symptoms of multiple sclerosis in women in relation to sex steroid exposure Maturitas 54 2006 149 153
13. S. Bansil, H.J. Lee, S. Jindal, C.R. Holtz, and S.D. Cook Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis Acta Neurol Scand 99 1999 91 94
14. C. Pozzilli, P. Falaschi, and C. Mainero MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns Neurology 53 1999 622 624
15. P. Holmqvist, M. Hammar, A.M. Landtblom, and J. Brynhildsen Symptoms of multiple sclerosis in women in relation to cyclical hormone changes Eur J Contracept Reprod Health Care 14 2009 365 370
16. L. Villard-Mackintosh, and M.P. Vessey Oral contraceptives and reproductive factors in multiple sclerosis incidence Contraception 47 1993 161 168
17. M. Thorogood, and P.C. Hannaford The influence of oral contraceptives on the risk of multiple sclerosis Br J Obstet Gynaecol 105 1998 1296 1299
18. M.A. Hernan, M.J. Hohol, M.J. Olek, D. Spiegelman, and A. Ascherio Oral contraceptives and the incidence of multiple sclerosis Neurology 55 2000 848 854
19. I. Korn-Lubetzki, E. Kahana, G. Cooper, and O. Abramsky Activity of multiple sclerosis during pregnancy and puerperium Ann Neurol 16 1984 229 231
20. C. Confavreux, M. Hutchinson, M.M. Hours, P. Cortinovis-Tourniaire, and T. Moreau Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group N Engl J Med 339 1998 285 291
21. R. Smith, and J.W. Studd A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle J R Soc Med 85 1992 612 613
22. Stuve O, Kieseier BC, Hemmer B, et al. Translational research in neurology and neuroscience 2010: multiple sclerosis. Arch Neurol; 2010, jul 12, [epub ahead of print] in press.
23. H. Offner Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis J Neurosci Res 78 2004 603 624
24. L. Garay, M.C. Gonzalez-Deniselle, A. Lima, P. Roig, and A.F. De Nicola Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis J Steroid Biochem Mol Biol 107 2007 228 237
25. S.M. Gold, and R.R. Voskuhl Estrogen treatment in multiple sclerosis J Neurol Sci 286 2009 99 103
26. M. Marin-Husstege, M. Muggironi, D. Raban, R.P. Skoff, and P. Casaccia-Bonnefil Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones Dev Neurosci 26 2004 245 254
27. A.M. Ghoumari, C. Ibanez, and M. El-Etr Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum J Neurochem 86 2003 848 859
28. A.M. Ghoumari, E.E. Baulieu, and M. Schumacher Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures Neuroscience 135 2005 47 58
29. G.R. John, S.L. Shankar, and B. Shafit-Zagardo Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation Nat Med 8 2002 1115 1121
30. H.A. Arnett, S.P. Fancy, and J.A. Alberta bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS Science 306 2004 2111 2115
31. A. Nicot Gender and sex hormones in multiple sclerosis pathology and therapy Front Biosci 14 2009 4477 4515
32. R.H. Straub The complex role of estrogens in inflammation Endocr Rev 28 2007 521 574
33. H.B. Liu, K.K. Loo, K. Palaszynski, J. Ashouri, D.B. Lubahn, and R.R. Voskuhl Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease J Immunol 171 2003 6936 6940
34. M.A. Yates, Y. Li, P.J. Chlebeck, and H. Offner GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol BMC Immunol 11 2010 20
35. B.F. Bebo Jr., A. Fyfe-Johnson, K. Adlard, A.G. Beam, A.A. Vandenbark, and H. Offner Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains J Immunol 166 2001 2080 2089
36. S.M. Gold, M.V. Sasidhar, and L.B. Morales Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha) Lab Invest 89 2009 1076 1083
37. L. Garidou, S. Laffont, and V. Douin-Echinard Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol- mediated inhibition of experimental autoimmune encephalomyelitis J Immunol 173 2004 2435 2442
38. M.J. Polanczyk, R.E. Jones, and S. Subramanian T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis Am J Pathol 165 2004 2069 2077
39. B. Calippe, V. Douin-Echinard, and L. Delpy 17{beta}-Estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor {alpha} signaling in macrophages in vivo J Immunol 185 2010 1169 1176
40. B. Calippe, V. Douin-Echinard, and M. Laffargue Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway J Immunol 180 2008 7980 7988
41. M. Kipp, and C. Beyer Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis Front Neuroendocrinol 30 2009 188 200
42. S.N. Giraud, C.M. Caron, D. Pham-Dinh, P. Kitabgi, and A.B. Nicot Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes Proc Natl Acad Sci USA 107 2010 8416 8421
43. T. Takao, N. Flint, L. Lee, X. Ying, J. Merrill, and K.J. Chandross 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death J Neurochem 89 2004 660 673
44. D. Manthey, and C. Behl From structural biochemistry to expression profiling: neuroprotective activities of estrogen Neuroscience 138 2006 845 850
45. A. Billon-Gales, C. Fontaine, and V. Douin-Echinard Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice Circulation 120 2009 2567 2576
46. M.A. De Leon-Nava, K. Nava, and G. Soldevila Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation J Steroid Biochem Mol Biol 113 2009 57 64
47. J. Szekeres-Bartho, M. Halasz, and T. Palkovics Progesterone in pregnancy; receptor-ligand interaction and signaling pathways J Reprod Immunol 83 2009 60 64
48. L. Garay, M.C. Gonzalez-Deniselle, and M. Meyer Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis Brain Res 1283 2009 177 185
49. M.A. Yates, Y. Li, P. Chlebeck, T. Proctor, A.A. Vandenbark, and H. Offner Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis J Neuroimmunol 220 2010 136 139
50. H.J. Yu, J. Fei, and X.S. Chen Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein Neurosci Lett 476 2010 42 45
51. R.L. Roof, R. Duvdevani, J.W. Heyburn, and D.G. Stein Progesterone rapidly decreases brain edema: treatment delayed up to 24 h is still effective Exp Neurol 138 1996 246 251
52. B.G. Arnason, and D.P. Richman Effect of oral contraceptives on experimental demyelinating disease Arch Neurol 21 1969 103 108
53. R.D. Brinton, R.F. Thompson, and M.R. Foy Progesterone receptors: form and function in brain Front Neuroendocrinol 29 2008 313 339
54. S. Tiwari-Woodruff, and R.R. Voskuhl Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice J Neurol Sci 286 2009 81 85
55. H.L. Koenig, M. Schumacher, and B. Ferzaz Progesterone synthesis and myelin formation by Schwann cells Science 268 1995 1500 1503
56. N. Gago, M. El-Etr, and N. Sananes 3alpha,5alpha-Tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation J Neurosci Res 78 2004 770 783
57. C. Ibanez, S.A. Shields, M. El-Etr, E.E. Baulieu, M. Schumacher, and R.J.M. Franklin Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats Neuropathol Appl Neurobiol 30 2004 80 89
58. P. Acs, M. Kipp, and A. Norkute 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice Glia 57 2009 807 814
59. M.M. Siegenthaler, M.K. Tu, and H.S. Keirstead The extent of myelin pathology differs following contusion and transection spinal cord injury J Neurotrauma 24 2007 1631 1646
60. F. Labombarda, S.L. Gonzalez, and A. Lima Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury Glia 57 2009 884 897
61. L. Cahill Why sex matters for neuroscience Nat Rev Neurosci 7 2006 477 484
62. M. Cerghet, R.P. Skoff, D. Bessert, Z. Zhang, C. Mullins, and M.S. Ghandour Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents J Neurosci 26 2006 1439 1447
63. W.W. Li, J. Penderis, C. Zhao, M. Schumacher, and R.J.M. Franklin Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS Exp Neurol 202 2006 250 254
64. N.L. Sicotte, S.M. Liva, and R. Klutch Treatment of multiple sclerosis with the pregnancy hormone estriol Ann Neurol 52 2002 421 428
65. S.S. Soldan, A.I. Alvarez Retuerto, N.L. Sicotte, and R.R. Voskuhl Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol J Immunol 171 2003 6267 6274
66. M. El-Etr, S. Vukusic, and L. Gignoux Steroid hormones in multiple sclerosis J Neurol Sci 233 2005 49 54
67. S. Vukusic, I. Ionescu, and M. El-Etr The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement J Neurol Sci 286 2009 114 118
68. N.L. Sicotte, B.S. Giesser, and V. Tandon Testosterone treatment in multiple sclerosis: a pilot study Arch Neurol 64 2007 683 688
69. D. Conway, and J.A. Cohen Combination therapy in multiple sclerosis Lancet Neurol 9 2010 299 308
70. R. Sitruk-Ware Pharmacological profile of progestins Maturitas 61 2008 151 157